Literature DB >> 12063043

Vitrectomy for diabetic cystoid macular edema.

Yukihiro Sato1, Zeon Lee, Hiroyuki Shimada.   

Abstract

PURPOSE: We evaluated visual outcomes following vitrectomy for diabetic cystoid macular edema.
METHODS: Visual outcomes and factors possibly influencing final visual acuity were assessed and documented retrospectively in 45 eyes of 40 patients, all of whom were followed up for at least 6 months postoperatively.
RESULTS: Compared with the preoperative logarithm of the minimum angle of resolution (logMAR) visual acuity, final logMAR visual acuity improved 0.2 or more in 51% of the eyes, was unchanged in 47%, and decreased 0.2 or more in 2%. A final postoperative visual acuity of 0.5 or better was achieved in 38%. Preoperative visual acuity and the extent of the cystoid space on fluorescein angiography were significantly related to final visual acuity. A final postoperative visual acuity of 0.5 or better was noted in 8% of eyes with a preoperative visual acuity below 0.1, in 50% of eyes with a preoperative visual acuity of 0.1 or better, in 71% of eyes with a cystoid space smaller than 5 disc areas, and in 20% of eyes with a cystoid space of 5 disc areas or more. The state of the posterior vitreous membrane did not influence final visual acuity. There were no complications that decreased visual acuity.
CONCLUSIONS: We conclude that diabetic cystoid macular edema is a good indication for vitrectomy, regardless of the state of the posterior vitreous membrane. A preoperative visual acuity of 0.1 or better and/or a cystoid space smaller than 5 disc areas may be indications for surgery aimed at achieving a final postoperative visual acuity of 0.5 or better.

Entities:  

Mesh:

Year:  2002        PMID: 12063043     DOI: 10.1016/s0021-5155(02)00471-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  7 in total

1.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

Authors:  Julia A Haller; Haijing Qin; Rajendra S Apte; Roy R Beck; Neil M Bressler; David J Browning; Ronald P Danis; Adam R Glassman; Joseph M Googe; Craig Kollman; Andreas K Lauer; Mark A Peters; Margaret E Stockman
Journal:  Ophthalmology       Date:  2010-03-17       Impact factor: 12.079

3.  Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.

Authors:  Yumi Kamura; Yukihiro Sato; Takako Isomae; Hiroyuki Shimada
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

4.  Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy.

Authors:  Yuka Shimonagano; Norihito Doi; Yoshihiro Noda; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-08-03       Impact factor: 2.447

5.  Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy.

Authors:  Yuka Shimonagano; Reiko Makiuchi; Miho Miyazaki; Norihito Doi; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

6.  Comparison of surgical procedures for vitreous surgery in diabetic macular edema.

Authors:  Tomoaki Shiba; Yumi Kamura; Fumihiko Yagi; Yukihiro Sato
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

7.  Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.

Authors:  Ferenc Kuhn; Gyöngyi Kiss; Viktória Mester; Zsuzsanna Szijártó; Bálint Kovács
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.